Editorial: Incretin agonists in the treatment of obesity

Front Endocrinol (Lausanne). 2023 Aug 9:14:1265826. doi: 10.3389/fendo.2023.1265826. eCollection 2023.
No abstract available

Keywords: Dual GIP/GLP-1R agonists; GIP; GLP-1; GLP-1R agonists; incretins; liraglutide; obesity; semaglutide.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Incretins* / therapeutic use
  • Obesity* / drug therapy


  • Incretins